CMD 193
Alternative Names: Hu3S193-CalichDMH; Hu3S193-CM; Monoclonal antibody 3S193Latest Information Update: 19 Aug 2020
Price :
$50 *
At a glance
- Originator Wyeth
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 07 Jul 2004 Data presented at the 40th Annual Meeting of the American Society of Clinical Oncology (ASCO-2004) have been added to the Cancer therapeutic trials and adverse events section
- 01 Apr 2003 Preclinical trials in Cancer in USA
- 01 Apr 2003 A preclinical study has been added to the Cancer pharmacodynamics section